language_icon
EN
HI

Kwality Pharmaceuticals Share price

KPL

2298.8

79.90 (3.60%)
NSE
BSE
Last updated on 2 Jun, 2026 | 15:31 IST
Today's High

2325.00

Today's Low

2180.00

52 Week Low

1561.00

52 Week High

2388.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Kwality Pharmaceuticals Chart

Kwality Pharmaceuticals Share Key Metrics

Volume
21081.00
Market Cap
2385.28 CR
LTQ@LTP
19@2298.80
ATP
2246.46
Var Margin
26.54 %
Circuit Range
1775.2-2662.6
Delivery %
51.79 %
Value
4.74 CR
ASM/GSM
No
Market Lot
1

Summary

Kwality Pharmaceuticals share price is ₹2298.8 as of 3 Jun, 2026. The stock Kwality Pharmaceuticals intraday movement has stayed between ₹2180.00 and ₹2325.00, while on a 52-week basis,Kwality Pharmaceuticals price 52 week high is ₹2388.00 & its 52 week low is ₹1561.00.
In terms of trading activity, Kwality Pharmaceuticals has recorded a volume of 21081 shares, The Kwality Pharmaceuticals has a market cap of ₹10376198 CR. The stock’s Average Traded Price (ATP) stands at ₹2246.46, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 19 @ ₹2298.80.
Kwality Pharmaceuticals operates within a circuit range of ₹1775.20 – ₹2662.60, with a Value of ₹4.74 CR. The Delivery Percentage for the day is 51.79%. Additionally, Kwality Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Kwality Pharmaceuticals Fundamentals

View More
P/E Ratio

34.19

P/B Ratio

6.96

Div. Yield

0

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Kwality Pharmaceuticals Resistance and Support

Pivot 2272.33

Resistance

First Resistance

2334.56

Second Resistance

2450.23

Third Resistance

2512.46

Support

First Support

2156.66

Second Support

2094.43

Third Support

1978.76

Kwality Pharmaceuticals Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

54.87%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

2.79%

Domestic Institutional Investors

0.36%

Retail

41.98%

Others

0%

Total Promoters
MAR '26
54.87%

Kwality Pharmaceuticals Corporate Actions

DateAgenda
2026-05-19Audited Results
2026-02-12Quarterly Results
2025-11-13Quarterly Results
2025-08-11Quarterly Results
2025-05-19Audited Results
2025-01-31Quarterly Results

Kwality Pharmaceuticals News

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2026

Kwality Pharmaceuticals announced record Q4 FY26 revenue of ₹157.11 cr, a 35.8% YoY increase, and FY26 PAT of ₹67.34 cr, up 69% YoY. The company also improved its EBITDA margins to 24% and received an ICRA credit rating upgrade to BBB+.
May 19 2026 11:49:38

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Kwality Pharmaceuticals has scheduled an analyst/investor conference call on May 19, 2026, at 5:00 PM. The call will discuss Q4 FY26 financial results and will be hosted by Go India Advisors.
May 14 2026 18:16:49

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026

Kwality Pharma will hold a board meeting on May 19, 2026, to consider and approve the standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026. This meeting will decide the company's financial performance for the last quarter and the full fiscal year.
May 08 2026 16:37:49

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Credit Rating

Kwality Pharmaceuticals Ltd's credit rating has been upgraded by ICRA to [ICRA]BBB+ (Stable)/[ICRA]A2. The company was also removed from the 'Issuer Not Cooperating' category, reflecting improved financial health and compliance.
May 08 2026 10:39:08
Read More

Kwality Pharmaceuticals Management

NamePosition
Gurpreet KaurCompany Secretary & Compliance Officer
Ramesh KumarManaging Director
View More

Kwality Pharmaceuticals FAQs

The Buying Price of Kwality Pharmaceuticals share is 2298.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Kwality Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kwality Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Kwality Pharmaceuticals shares is 34.19. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Kwality Pharmaceuticals shares is 6.96. Useful to assess the stock's value relative to its book value.

To assess Kwality Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Kwality Pharmaceuticals is 2385.28 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Kwality Pharmaceuticals share price is 2388.00 & 1561.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Kwality Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost